Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial

Trials
Fang YuanCHASE Study Group

Abstract

No ideal blood pressure (BP) range has been scientifically determined for acute stroke, and no studies on BP management have been carried out for patients with severe stroke. This trial aims to investigate whether individualized lowering of elevated BP would improve the outcome in patients with severe stroke. The CHASE trial is a multicenter, randomized, controlled study. A total of 500 adult patients with acute severe stroke will be enrolled in 18 study sites in China and randomized to individualized BP lowering (10-15% reduction from admission level) or guideline-recommended BP lowering. The primary outcome measurement is the proportion of participants with a poor outcome (modified Rankin Scale ≥ 3) at day 90 of enrollment. Secondary outcomes include disability at hospital discharge and the ability of activities of daily living at day 90 of enrollment. The relationship between intervention and the primary outcome will be analyzed using multivariate logistic regression adjusted for study site, demographics, and baseline characteristics. The CHASE trial will be the first study to explore the optimum BP management for acute severe stroke. This trial potentially offers a strong argument for individualized target for lowering elev...Continue Reading

References

Jun 1, 1989·American Journal of Hypertension·S Strandgaard, O B Paulson
Aug 31, 2000·Critical Care Medicine·J BerrouschotD Schneider
Sep 8, 2001·Stroke; a Journal of Cerebral Circulation·S E KasnerD W Krieger
Oct 5, 2002·Stroke; a Journal of Cerebral Circulation·Peter AppelrosAndreas Terént
Jan 28, 2003·Archives of Internal Medicine·Andrea SempliciniAchille C Pessina
Jun 21, 2003·Stroke; a Journal of Cerebral Circulation·Joachim SchraderUNKNOWN Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group
Jan 17, 2004·Stroke; a Journal of Cerebral Circulation·José CastilloAntoni Dávalos
Mar 24, 2004·Journal of Human Hypertension·K N VemmosD Vassilopoulos
Dec 13, 2006·The American Journal of Emergency Medicine·Adnan I QureshiAlluru S Reddi
Apr 9, 2008·Lancet Neurology·Craig S AndersonUNKNOWN INTERACT Investigators
Nov 13, 2012·Journal of Thrombosis and Haemostasis : JTH·O BillP Michel
May 30, 2013·The New England Journal of Medicine·Craig S AndersonUNKNOWN INTERACT2 Investigators
Nov 19, 2013·JAMA : the Journal of the American Medical Association·Jiang HeUNKNOWN CATIS Investigators
Jun 9, 2016·The New England Journal of Medicine·Adnan I QureshiUNKNOWN ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network
Jul 2, 2016·The Neurohospitalist·Ahmad AlSibai, Adnan I Qureshi

❮ Previous
Next ❯

Citations

Jun 12, 2020·International Journal of Stroke : Official Journal of the International Stroke Society·Fang YuanWen Jiang
Nov 24, 2020·The Journal of Clinical Hypertension·Jingjing ZhaoUNKNOWN CHASE Study Group
Sep 30, 2021·Annals of Clinical and Translational Neurology·Jingjing ZhaoUNKNOWN CHASE Study Group

❮ Previous
Next ❯

Software Mentioned

CHASE
SPSS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.